<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Digital Diagnostics</journal-id><journal-title-group><journal-title xml:lang="en">Digital Diagnostics</journal-title><trans-title-group xml:lang="ru"><trans-title>Digital Diagnostics</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Digital Diagnostics</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2712-8490</issn><issn publication-format="electronic">2712-8962</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">71434</article-id><article-id pub-id-type="doi">10.17816/DD71434</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Reviews</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Научные обзоры</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="zh"><subject>科学评论</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Methods of medical visualization and thermal ablation as a new approach to treatment of hyperparathyroidism</article-title><trans-title-group xml:lang="ru"><trans-title>Современные технологии визуализации и термоаблации очагов гиперпаратиреоза</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>甲状旁腺功能亢进病灶可视化和热消融的现代技术</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7721-634X</contrib-id><contrib-id contrib-id-type="spin">7085-7976</contrib-id><name-alternatives><name xml:lang="en"><surname>Rumiantsev</surname><given-names>Pavel O.</given-names></name><name xml:lang="ru"><surname>Румянцев</surname><given-names>Павел Олегович</given-names></name><name xml:lang="zh"><surname>Rumiantsev</surname><given-names>Pavel</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>доктор мед наук, заместитель главного врача, главный онколог–радиолог, член Российского общества специалистов по опухолям головы и шеи</p></bio><bio xml:lang="zh"><p>MD, Dr. Sci. (Med.)</p></bio><email>pavelrum@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5877-6982</contrib-id><contrib-id contrib-id-type="spin">9380-1293</contrib-id><name-alternatives><name xml:lang="en"><surname>Bubnov</surname><given-names>Aleksandr A.</given-names></name><name xml:lang="ru"><surname>Бубнов</surname><given-names>Александр Андреевич</given-names></name><name xml:lang="zh"><surname>Bubnov</surname><given-names>Aleksandr A.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>graduate student</p></bio><bio xml:lang="ru"><p>аспирант, медицинский физик института, онкоэндокринологии отделения радионуклидной терапии МИФИ</p></bio><bio xml:lang="zh"><p>graduate student</p></bio><email>bubnov96@mail.ru</email><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5652-2607</contrib-id><name-alternatives><name xml:lang="en"><surname>Degtyarev</surname><given-names>Mikhail V.</given-names></name><name xml:lang="ru"><surname>Дегтярев</surname><given-names>Михаил Владимирович</given-names></name><name xml:lang="zh"><surname>Degtyarev</surname><given-names>Mikhail V.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, radiologist</p></bio><bio xml:lang="ru"><p>врач-радиолог, заведующий отделением радионуклидной диагностики</p></bio><bio xml:lang="zh"><p>MD, radiologist</p></bio><email>germed@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3220-2438</contrib-id><name-alternatives><name xml:lang="en"><surname>Slushchuk</surname><given-names>Konstantin Y.</given-names></name><name xml:lang="ru"><surname>Слащук</surname><given-names>Константин Юрьевич</given-names></name><name xml:lang="zh"><surname>Slushchuk</surname><given-names>Konstantin Y.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, endocrinologist, researcher</p></bio><bio xml:lang="ru"><p>врач-эндокринолог, научный сотрудник отделения радионуклидной диагностики</p></bio><bio xml:lang="zh"><p>MD, endocrinologist, researcher</p></bio><email>slashuk911@gmail.com</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6059-2827</contrib-id><contrib-id contrib-id-type="spin">9441-4035</contrib-id><name-alternatives><name xml:lang="en"><surname>Zakharova</surname><given-names>Svetlana M.</given-names></name><name xml:lang="ru"><surname>Захарова</surname><given-names>Светлана Михайловна</given-names></name><name xml:lang="zh"><surname>Zakharova</surname><given-names>Svetlana M.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>кандидат медицинских наук, старший научный сотрудник, лечебно-реабилитационный отдел</p></bio><bio xml:lang="zh"><p>MD, Cand. Sci. (Med.)</p></bio><email>smzakharova@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2995-7140</contrib-id><name-alternatives><name xml:lang="en"><surname>Agibalov</surname><given-names>Dmitriy Y.</given-names></name><name xml:lang="ru"><surname>Агибалов</surname><given-names>Дмитрий Юрьевич</given-names></name><name xml:lang="zh"><surname>Agibalov</surname><given-names>Dmitriy Y.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>doctor</p></bio><bio xml:lang="ru"><p>врач-хирург, врач УЗИ, флеболог, старший преподаватель кафедры хирургических болезней, руководитель клиники Доктор Плюс</p></bio><bio xml:lang="zh"><p>doctor</p></bio><email>agibalovd@bk.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3234-1427</contrib-id><contrib-id contrib-id-type="spin">7536-2368</contrib-id><name-alternatives><name xml:lang="en"><surname>Timoshenko</surname><given-names>Viktor Y.</given-names></name><name xml:lang="ru"><surname>Тимошенко</surname><given-names>Виктор Юрьевич</given-names></name><name xml:lang="zh"><surname>Timoshenko</surname><given-names>Viktor Y.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Phys-Math), Professor</p></bio><bio xml:lang="ru"><p>доктор физико-математических наук, профессор кафедры физики низких температур и сверхпроводимости физического факультета МГУ, главный научный сотрудник</p></bio><bio xml:lang="zh"><p>Dr. Sci. (Phys-Math), Professor</p></bio><email>vtimoshe@gmail.com</email><xref ref-type="aff" rid="aff3"/><xref ref-type="aff" rid="aff4"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">International Medical Center “SOGAZ”</institution></aff><aff><institution xml:lang="ru">Международный медицинский центр «СОГАЗ МЕДИЦИНА»</institution></aff><aff><institution xml:lang="zh">International Medical Center “SOGAZ”</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Endocrinology Research Centre</institution></aff><aff><institution xml:lang="ru">Национальный медицинский исследовательский центр эндокринологии</institution></aff><aff><institution xml:lang="zh">Endocrinology Research Centre</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)</institution></aff><aff><institution xml:lang="ru">Национальный исследовательский ядерный университет МИФИ</institution></aff><aff><institution xml:lang="zh">National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Lomonosov Moscow State University</institution></aff><aff><institution xml:lang="ru">Московский государственный университет имени М.В. Ломоносова</institution></aff><aff><institution xml:lang="zh">Lomonosov Moscow State University</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2021-09-02" publication-format="electronic"><day>02</day><month>09</month><year>2021</year></pub-date><pub-date date-type="pub" iso-8601-date="2021-10-15" publication-format="electronic"><day>15</day><month>10</month><year>2021</year></pub-date><volume>2</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><issue-title xml:lang="zh"/><fpage>369</fpage><lpage>385</lpage><history><date date-type="received" iso-8601-date="2021-06-10"><day>10</day><month>06</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-08-17"><day>17</day><month>08</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, Rumiantsev P.O., Bubnov A.A., Degtyarev M.V., Slushchuk K.Y., Zakharova S.M., Agibalov D.Y., Timoshenko V.Y.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, Румянцев П.О., Бубнов А.А., Дегтярев М.В., Слащук К.Ю., Захарова С.М., Агибалов Д.Ю., Тимошенко В.Ю.</copyright-statement><copyright-statement xml:lang="zh">Copyright ©; 2021, Rumiantsev P., Bubnov A.A., Degtyarev M.V., Slushchuk K.Y., Zakharova S.M., Agibalov D.Y., Timoshenko V.Y.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">Rumiantsev P.O., Bubnov A.A., Degtyarev M.V., Slushchuk K.Y., Zakharova S.M., Agibalov D.Y., Timoshenko V.Y.</copyright-holder><copyright-holder xml:lang="ru">Румянцев П.О., Бубнов А.А., Дегтярев М.В., Слащук К.Ю., Захарова С.М., Агибалов Д.Ю., Тимошенко В.Ю.</copyright-holder><copyright-holder xml:lang="zh">Rumiantsev P., Bubnov A.A., Degtyarev M.V., Slushchuk K.Y., Zakharova S.M., Agibalov D.Y., Timoshenko V.Y.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://jdigitaldiagnostics.com/DD/article/view/71434">https://jdigitaldiagnostics.com/DD/article/view/71434</self-uri><abstract xml:lang="en"><p>The pathologies of parathyroid glands are widespread among endocrine system diseases, excluding diabetes and thyroid pathology. There are only two methods that are used to treat hyperparathyroidisms, such as surgery and conservative therapy. However, transracial thermal destruction methods (ablation) have recently appeared in clinical practice. The methods have good precision and connect with physical phenomena, such as interaction laser, radiofrequency, microwave, and HIFU irradiation with bio substance. The review is dedicated to critically analyze the modern methods for local thermal destruction of the hyper-functioning parathyroid glands. The review includes data from randomized clinical trials from 2012 to 2021. The studies were from Google Scholar and Pubmed with a total number of 1,938 patients (laser ablation ― 216 patients, radiofrequency ablation ― 225, microwave ablation ― 1467, high-density ultrasound ablation ― 30 patients). Recommendations methods of thermal destruction application were obtained during the review. Furthermore, we have designed some algorithms for hyperparathyroidism treatment. Moreover, thermal destruction methods were observed. There are four modern methods of thermal destruction which have been analyzed like alternatives to surgery. Each of them has advantages and disadvantages, its profile of safety and effectiveness. After processing information from a proven database, the most popular among specialists is methods of microwave ablation. However, laser ablation is more effective than other ways.</p></abstract><trans-abstract xml:lang="ru"><p>Патология околощитовидных желёз по частоте встречаемости находится на третьем месте среди эндокринных болезней, уступая сахарному диабету и заболеваниям щитовидной железы. На сегодняшний день в клинической практике широко применяются только два метода лечения гиперпаратиреоза ― консервативный и хирургический. Однако в последние время помимо них появились способы транскутанной термодеструкции (аблации), основанные на прицельном физическом воздействии ― лазерном, радиочастотном, микроволновом, ультразвуковом. Настоящий обзор посвящён критическому анализу современного арсенала методов локальной термодеструкции гиперфункции околощитовидных желёз при гиперпаратиреозе. Цель обзора ― показать возможности современных неинвазивных и малоинвазивных методов лечения гиперпаратиреоза без противопоставления их хирургическому методу. В обзор включены данные рандомизированных клинических исследований за период с 2012 по 2021 г., найденных в Google Scholar, Pubmed. Общее количество пациентов ― 1938 (лазерная аблация ― 216, радиочастотная аблация ― 225, микроволновая аблация ― 1467, аблация ультразвуком высокой плотности ― 30). Получены критерии применимости методов термодеструкции. Составлен алгоритм по лечению гиперпаратиреоза. Таким образом, в качестве альтернативы хирургическому вмешательству проанализированы четыре современных метода термодеструкции патологически изменённых околощитовидных желёз, каждый из которых имеет преимущества и недостатки, свой профиль эффективности и безопасности. Как показывает анализ существующей доказательной практики, наибольшей популярностью среди клиницистов пользуется метод микроволновой аблации, однако более эффективным методом термодеструкции гиперфункционирующих околощитовидных желёз является лазерная аблация.</p></trans-abstract><trans-abstract xml:lang="zh"><p>甲状旁腺病理学在内分泌疾病中居第三位，仅次于糖尿病和甲状腺疾病。 目前，只有两种治疗甲状腺功能亢进的方法被广泛应用于临床：保守的和手术的。然而，最近还出现了基于激光、射频、微波等目标物理效应的跨层热分解（消融）方法，超声波。本综述致力于对甲状腺功能亢进的局部热分解方法的现代武库进行批判性分析。本综述的目的是展示现代无创和微创方法治疗甲状旁腺功能亢进的可能性，同时又不反对手术方法。 该综述包括2012年至2021年期间在谷歌学者（Google Scholar，PubMed）中发现的随机临床研究数据。患者总数-1938人（激光消融216人，射频消融225人，微波消融1467人，高密度超声消融30人）。 获得了热分解方法的适用性标准。建立了治疗甲状腺功能亢进的算法。因此，作为手术干预的替代方法，已经分析了四种现代热破坏病理改变的甲状旁腺方法，每种方法都有优点和缺点，其自身的有效性和安全性。 对现有循证实践的分析表明，最受临床医生欢迎的是微波消融方法，而激光消融是一种更有效的热破坏功能亢进的甲状旁腺的方法。</p></trans-abstract><kwd-group xml:lang="en"><kwd>hyperparathyroidism</kwd><kwd>thermal destruction</kwd><kwd>ablation of parathyroid glands</kwd><kwd>laser ablation</kwd><kwd>radiofrequency ablation</kwd><kwd>microwave ablation</kwd><kwd>HIFU ablation</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>гиперпаратиреоз</kwd><kwd>термодеструкция</kwd><kwd>аблация околощитовидных желёз</kwd><kwd>лазерная аблация</kwd><kwd>радиочастотная аблация</kwd><kwd>микроволновая аблация</kwd><kwd>HIFU-аблация</kwd></kwd-group><kwd-group xml:lang="zh"><kwd>甲状旁腺功能亢进</kwd><kwd>热破坏</kwd><kwd>甲状旁腺消融</kwd><kwd>激光烧蚀</kwd><kwd>射频消融</kwd><kwd>微波消融</kwd><kwd>HIFU 消融。</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Fraser WD. Hyperparathyroidism. Lancet. 2009;374(9684): 145–158. doi: 10.1016/S0140-6736(09)60507-9</mixed-citation><mixed-citation xml:lang="ru">Fraser W.D. Hyperparathyroidism//Lancet. 2009. Vol. 374, N 9684. P. 145–158. doi: 10.1016/S0140-6736(09)60507-9</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Vadiveloo T, Donnan PT, Leese GP. A population-based study of the epidemiology of chronic hypoparathyroidism. J Bone Miner Res. 2018;33(3):478–485. doi: 10.1002/jbmr.3329</mixed-citation><mixed-citation xml:lang="ru">Vadiveloo T., Donnan P.T., Leese G.P. A population-based study of the epidemiology of chronic hypoparathyroidism//J Bone Miner Res. 2018. Vol. 33, N 3. Р. 478–485. doi: 10.1002/jbmr.3329</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Yanevskaya LG, Karonova TL, Sleptsov IV, et al. Primary hyperparathyroidism: clinical forms and their features. Retrospective study. Clinical and Experimental Thyroidology. 2019;15(1):19–29. (In Russ). doi: 10.14341/ket10213</mixed-citation><mixed-citation xml:lang="ru">Яневская Л.Г., Каронова Т.Л., Слепцов И.В., и др. Первичный гиперпаратиреоз: клинические формы и их особенности. Результаты ретроспективного исследования//Клиническая и экспериментальная тиреоидология. 2019. T. 15, № 1. C. 19–29. doi: 10.14341/ket10213</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Mokrysheva NG, Eremkina AK, Mirnaya SS, et al. Challenges in differential diagnosis between primary and secondary forms of hyperparathyroidism. Obesity and Metabolism. 2017;14(3):48–53. (In Russ). doi: 10.14341/omet2017348-53</mixed-citation><mixed-citation xml:lang="ru">Мокрышева Н.Г., Еремкина А.К., Мирная С.С., Ковалева Е.В. Трудности дифференциальной диагностики между первичной и вторичной формами гиперпаратиреоза//Ожирение и метаболизм. 2017. T. 14, № 3. C. 48–53. doi: 10.14341/omet2017348-53</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Smorshchok VN, Kuznetsov NS, Artemova AM, et al. Surgical treatment of patients with secondary hyperparathyroidism in chronic renal failure. Problems of Endocrinology. 2003;49(6):36–41. (In Russ). doi: 10.14341/probl11761</mixed-citation><mixed-citation xml:lang="ru">Сморщок В.Н., Кузнецов Н.С., Артемова А.М., и др. Xирургическое лечение больных с вторичным гиперпаратиреозом при хронической почечной недостаточности//Проблемы эндокринологии. 2003. Т. 49, № 6. С. 36–41. doi: 10.14341/probl11761</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Slashchuk KY, Degtyarev MV, Rumyantsev PO, et al. Imaging methods of the parathyroid glands in primary hyperparathyroidism. Literature review. Endocrine Surgery. 2019;13(4):153–174. (In Russ). doi: 10.14341/serg12241</mixed-citation><mixed-citation xml:lang="ru">Слащук К.Ю., Дегтярев М.В., Румянцев П.О., и др. Методы визуализации околощитовидных желез при первичном гиперпаратиреозе. Обзор литературы//Эндокринная хирургия. 2019. T. 13, № 4. С. 153–174. doi: 10.14341/serg12241</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Broos WM, van der Zant FM, Knol JJ, Wondergem M. Choline PET/CT in parathyroid imaging: a systematic review. Nucl Med Commun. 2019;40(2):96–105. doi: 10.1097/MNM.0000000000000952</mixed-citation><mixed-citation xml:lang="ru">Broos W.M., van der Zant F.M., Knol J.J., Wondergem M. Choline PET/CT in parathyroid imaging: a systematic review//Nucl Med Commun. 2019. Vol. 40, N 2. P. 96–105. doi: 10.1097/MNM.0000000000000952</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Yu N, Leese GP, Smith D, Donnan PT. The natural history of treated and untreated primary hyperparathyroidism: the parathyroid epidemiology and audit research study. QJM. 2011;104(6):513–521. doi: 10.1093/qjmed/hcq261</mixed-citation><mixed-citation xml:lang="ru">Yu N., Leese G.P., Smith D., Donnan P.T. The natural history of treated and untreated primary hyperparathyroidism: the parathyroid epidemiology and audit research study//QJM. 2011. Vol. 104, N 6. P. 513–521. doi: 10.1093/qjmed/hcq261</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Ishii H, Stechman MJ, Watkinson JC, et al. A review of parathyroid surgery for primary hyperparathyroidism from the United Kingdom Registry of Endocrine and Thyroid Surgery (UKRETS). World J Surg. 2021;45:782–789. doi: 10.1007/s00268-020-05885-5</mixed-citation><mixed-citation xml:lang="ru">Ishii H., Stechman M.J., Watkinson J.C., et al. A review of parathyroid surgery for primary hyperparathyroidism from the United Kingdom Registry of Endocrine and Thyroid Surgery (UKRETS)//World J Surg. 2021. Vol. 45. P. 782–789. doi: 10.1007/s00268-020-05885-5</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Kim MS, Kim GH, Lee CH, et al. Surgical outcomes of subtotal parathyroidectomy for renal hyperparathyroidism. Clin Exp Otorhinolaryngol. 2020;13(2):173–178. doi: 10.21053/ceo.2019.01340</mixed-citation><mixed-citation xml:lang="ru">Kim M.S., Kim G.H., Lee C.H., et al. Surgical outcomes of subtotal parathyroidectomy for renal hyperparathyroidism//Clin Exp Otorhinolaryngol. 2020. Vol. 13, N 2. P. 173–178. doi: 10.21053/ceo.2019.01340</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">LeBlanc RA, Isaac A, Abele J, et al. Validation of a novel method for localization of parathyroid adenomas using SPECT/CT. J Otolaryngol Head Neck Surg. 2018;47(1):65. doi: 10.1186/s40463-018-0307-6</mixed-citation><mixed-citation xml:lang="ru">LeBlanc R.A., Isaac A., Abele J., et al. Validation of a novel method for localization of parathyroid adenomas using SPECT/CT//J Otolaryngol Head Neck Surg. 2018. Vol. 47, N 1. P. 65. doi: 10.1186/s40463-018-0307-6</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Zhao S, Guo X, Taniguchi M, et al. Detection of mediastinal lymph node metastases using indocyanine green (ICG) fluorescence imaging in an orthotopic implantation model. Anticancer Res. 2020;40(4):1875–1882. doi: 10.21873/anticanres.14141</mixed-citation><mixed-citation xml:lang="ru">Zhao S., Guo X., Taniguchi M., et al. Detection of mediastinal lymph node metastases using indocyanine green (ICG) fluorescence imaging in an orthotopic implantation model//Anticancer Res. 2020. Vol. 40, N 4. P. 1875–1882. doi: 10.21873/anticanres.14141</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Kose E, Rudin AV, Kahramangil B, et al. Autofluorescence imaging of parathyroid glands: An assessment of potential indications. Surgery. 2020;167(1):173–179. doi: 10.1016/j.surg.2019.04.072</mixed-citation><mixed-citation xml:lang="ru">Kose E., Rudin A.V., Kahramangil B., et al. Autofluorescence imaging of parathyroid glands: An assessment of potential indications//Surgery. 2020. Vol. 167, N 1. Р. 173–179. doi: 10.1016/j.surg.2019.04.072</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Wu B, Haigh PI, Hwang R, et al. Underutilization of parathyroidectomy in elderly patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 2010;95(9):4324–4330. doi: 10.1210/jc.2009-2819</mixed-citation><mixed-citation xml:lang="ru">Wu B., Haigh P.I., Hwang R., et al. Underutilization of parathyroidectomy in elderly patients with primary hyperparathyroidism//J Clin Endocrinol Metab. 2010. Vol. 95, N 9. Р. 4324–4330 doi: 10.1210/jc.2009-2819</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Kovatcheva RD, Vlahov JD, Stoinov JI, et al. High-intensity focused ultrasound (HIFU) treatment in uraemic secondary hyperparathyroidism. Nephrol Dial Transplant. 2012;27(1):76–80. doi: 10.1093/ndt/gfr590</mixed-citation><mixed-citation xml:lang="ru">Kovatcheva R.D., Vlahov J.D., Stoinov J.I., et al. High-intensity focused ultrasound (HIFU) treatment in uraemic secondary hyperparathyroidism//Nephrol Dial Transplant. 2012. Vol. 27, N 1. P. 76–80. doi: 10.1093/ndt/gfr590</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Korkusuz H, Nimsdorf F, Happel C, et al. Percutaneous microwave ablation of benign thyroid nodules. Functional imaging in comparison to nodular volume reduction at a 3-month follow-up. Nuklearmedizin. 2015;54(1):13–19. doi: 10.3413/Nukmed-0678-14-06</mixed-citation><mixed-citation xml:lang="ru">Korkusuz H., Nimsdorf F., Happel C., et al. Percutaneous microwave ablation of benign thyroid nodules. Functional imaging in comparison to nodular volume reduction at a 3-month follow-up//Nuklearmedizin. 2015. Vol. 54, N 1. P. 13–19. doi: 10.3413/Nukmed-0678-14-06</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Zeng Z, Peng CZ, Liu JB, et al. Efficacy of ultrasound-guided radiofrequency ablation of parathyroid hyperplasia: single session vs. two-session for effect on hypocalcemia. Sci Rep. 2020;10(1):6206. doi: 10.1038/s41598-020-63299-8</mixed-citation><mixed-citation xml:lang="ru">Zeng Z., Peng C.Z., Liu J.B., et al. Efficacy of ultrasound-guided radiofrequency ablation of parathyroid hyperplasia: single session vs. two-session for effect on hypocalcemia//Sci Rep. 2020. Vol. 10, N 1. P. 6206. doi: 10.1038/s41598-020-63299-8</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Casara D, Rubello D, Piotto A, Pelizzo MR. 99mTc-MIBI radio-guided minimally invasive parathyroid surgery planned on the basis of a preoperative combined 99mTc-pertechnetate/99mTc-MIBI and ultrasound imaging protocol. Eur J Nucl Med. 2000;27(9):1300–1304. doi: 10.1007/s002590000297</mixed-citation><mixed-citation xml:lang="ru">Casara D., Rubello D., Piotto A., Pelizzo M.R. 99mTc-MIBI radio-guided minimally invasive parathyroid surgery planned on the basis of a preoperative combined 99mTc-pertechnetate/99mTc-MIBI and ultrasound imaging protocol//Eur J Nucl Med. 2000. Vol. 27, N 9. P. 1300–1304. doi: 10.1007/s002590000297</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Huang Z, Lou C. 99mTcO4-/99mTc-MIBI dual-tracer scintigraphy for preoperative localization of parathyroid adenomas. J Int Med Res. 2019;47(2):836–845. doi: 10.1177/0300060518813742</mixed-citation><mixed-citation xml:lang="ru">Huang Z., Lou C. 99mTcO4-/99mTc-MIBI dual-tracer scintigraphy for preoperative localization of parathyroid adenomas//J Int Med Res. 2019. Vol. 47, N 2. P. 836–845. doi: 10.1177/0300060518813742</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Zhang R, Zhang Z, Huang P, et al. Diagnostic performance of ultrasonography, dual-phase 99mTc-MIBI scintigraphy, early and delayed 99mTc-MIBI SPECT/CT in preoperative parathyroid gland localization in secondary hyperparathyroidism. BMC Med Imaging. 2020;20(1):91. doi: 10.1186/s12880-020-00490-3</mixed-citation><mixed-citation xml:lang="ru">Zhang R., Zhang Z., Huang P., et al. Diagnostic performance of ultrasonography, dual-phase 99mTc-MIBI scintigraphy, early and delayed 99mTc-MIBI SPECT/CT in preoperative parathyroid gland localization in secondary hyperparathyroidism//BMC Med Imaging. 2020. Vol. 20, N 1. P. 91. doi: 10.1186/s12880-020-00490-3</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Treglia G, Sadeghi R, Schalin-Jäntti C, et al. Detection rate of 99m Tc-MIBI single photon emission computed tomography (SPECT)/CT in preoperative planning for patients with primary hyperparathyroidism: A meta-analysis. Head Neck. 2016;38(Suppl 1):2159–2172. doi: 10.1002/hed.24027</mixed-citation><mixed-citation xml:lang="ru">Treglia G., Sadeghi R., Schalin-Jäntti C., et al. Detection rate of 99m Tc-MIBI single photon emission computed tomography (SPECT)/CT in preoperative planning for patients with primary hyperparathyroidism: A meta-analysis//Head Neck. 2016. Vol. 38, Suppl 1. P. 2159–2172. doi: 10.1002/hed.24027</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">Huber GF, Hüllner M, Schmid C, et al. Benefit of 18F-fluorocholine PET imaging in parathyroid surgery. Eur Radiol. 2018;28(6):2700–2707. doi: 10.1007/s00330-017-5190-4</mixed-citation><mixed-citation xml:lang="ru">Huber G.F., Hüllner M., Schmid C., et al. Benefit of 18F-fluorocholine PET imaging in parathyroid surgery//Eur Radiol. 2018. Vol. 28, N 6. P. 2700–2707. doi: 10.1007/s00330-017-5190-4</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">Pacella CM, Mauri G. History of laser ablation. image-guided laser ablation. Springer, Cham; 2020. doi: 10.1007/978-3-030-21748-8_1</mixed-citation><mixed-citation xml:lang="ru">Pacella C.M., Mauri G. History of laser ablation. Image-guided laser ablation. Springer, Cham. 2020. doi: 10.1007/978-3-030-21748-8_1</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">Bown SG. Phototherapy in tumors. World J Surg. 1983;7(6):700–709. doi: 10.1007/BF01655209</mixed-citation><mixed-citation xml:lang="ru">Bown S.G. Phototherapy in tumors//World J Surg. 1983. Vol. 7, N 6. P. 700–709. doi: 10.1007/BF01655209</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">Appelbaum L, Goldberg SN, Ierace T, Mauri G. US-guided laser treatment of parathyroid adenomas. Int J Hyperthermia. 2020;37(1):366–372. doi: 10.1080/02656736.2020.1750712</mixed-citation><mixed-citation xml:lang="ru">Appelbaum L., Goldberg S.N., Ierace T., Mauri G. US-guided laser treatment of parathyroid adenomas//Int J Hyperthermia. 2020. Vol. 37, N 1. P. 366–372. doi: 10.1080/02656736.2020.1750712</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">Rhim H, Goldberg SN, Dodd GD, et al. Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors. Radiographics. 2001;21:S17–S35. doi: 10.1148/radiographics.21.suppl_1.g01oc11s17</mixed-citation><mixed-citation xml:lang="ru">Rhim H., Goldberg S.N., Dodd G.D., et al. Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors//Radiographics. 2001. Vol. 21. P. 17–35. doi: 10.1148/radiographics.21.suppl_1.g01oc11s17</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">McGahan JP, Dodd G. Radiofrequency ablation of the liver. American Journal of Roentgenology. 2001;176(1): 3–16 doi: 10.2214 / ajr.176.1.1760003</mixed-citation><mixed-citation xml:lang="ru">McGahan J.P., Dodd G. Radiofrequency ablation of the liver//American Journal of Roentgenology. 2001. Vol. 176, N 1. P. 3–16. doi 10.2214 / ajr.176.1.1760003</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">Hong K, Georgiades C. Radiofrequency ablation: mechanism of action and devices. J Vasc Interv Radiol. 2010;21(8 Suppl):179–186. doi: 10.1016/j.jvir.2010.04.008</mixed-citation><mixed-citation xml:lang="ru">Hong K., Georgiades C. Radiofrequency ablation: mechanism of action and devices//J Vasc Interv Radiol. 2010. Vol. 21, Suppl 8. P. 179–186. doi: 10.1016/j.jvir.2010.04.008</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">Zhang M, Tufano RP, Russell JO. Ultrasound-Guided radiofrequency ablation versus surgery for low-risk papillary thyroid microcarcinoma: results of over 5 years’ follow-up. Thyroid. 2020;30(3):408–417. doi: 10.1089/thy.2019.0147</mixed-citation><mixed-citation xml:lang="ru">Zhang M., Tufano R.P., Russell J.O. Ultrasound-Guided radiofrequency ablation versus surgery for low-risk papillary thyroid microcarcinoma: results of over 5 years’ follow-up//Thyroid. 2020. Vol. 30, N 3. P. 408–417. doi: 10.1089/thy.2019.0147</mixed-citation></citation-alternatives></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">Schullian P, Johnston EW, Putzer D, et al. Safety and efficacy of stereotactic radiofrequency ablation for very large (≥8 cm) primary and metastatic liver tumors. Sci Rep. 2020;10(1):1618. doi: 10.1038/s41598-020-58383-y</mixed-citation><mixed-citation xml:lang="ru">Schullian P., Johnston E.W., Putzer D., et al. Safety and efficacy of stereotactic radiofrequency ablation for very large (≥8 cm) primary and metastatic liver tumors//Sci Rep. 2020. Vol. 10, N 1. P. 1618. doi: 10.1038/s41598-020-58383-y</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><citation-alternatives><mixed-citation xml:lang="en">Marshall HR, Shakeri S, Hosseiny M, et al. Long-term survival after percutaneous radiofrequency ablation of pathologically proven renal cell carcinoma in 100 patients. J Vasc Interv Radiol. 2020;31(1):15–24. doi: 10.1016/j.jvir.2019.09.011</mixed-citation><mixed-citation xml:lang="ru">Marshall H.R., Shakeri S., Hosseiny M., et al. Long-Term survival after percutaneous radiofrequency ablation of pathologically proven renal cell carcinoma in 100 patients//J Vasc Interv Radiol. 2020. Vol. 31, N 1. P. 15–24. doi: 10.1016/j.jvir.2019.09.011</mixed-citation></citation-alternatives></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">Laird AM, Libutti SK. Minimally invasive parathyroidectomy versus bilateral neck exploration for primary hyperparathyroidism. Surg Oncol Clin N Am. 2016;25(1):103–118. doi: 10.1016/j.soc.2015.08.012</mixed-citation><mixed-citation xml:lang="ru">Laird A.M., Libutti S.K. Minimally invasive parathyroidectomy versus bilateral neck exploration for primary hyperparathyroidism//Surg Oncol Clin N Am. 2016. Vol. 25, N 1. P. 103–118. doi: 10.1016/j.soc.2015.08.012</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><citation-alternatives><mixed-citation xml:lang="en">Ha EJ, Baek JH, Baek SM. Minimally invasive treatment for benign parathyroid lesions: treatment efficacy and safety based on nodule characteristics. Korean J Radiol. 2020;21(12):1383–1392. doi: 10.3348/kjr.2020.0037</mixed-citation><mixed-citation xml:lang="ru">Ha E.J., Baek J.H., Baek S.M. Minimally invasive treatment for benign parathyroid lesions: treatment efficacy and safety based on nodule characteristics//Korean J Radiol. 2020. Vol. 21, N 12. P. 1383–1392. doi: 10.3348/kjr.2020.0037</mixed-citation></citation-alternatives></ref><ref id="B34"><label>34.</label><citation-alternatives><mixed-citation xml:lang="en">Sidorov DV, Stepanov SO, Grishin NA, et al. Microwave ablation in the treatment of liver malignancies. Oncology. Journal named after P.A. Herzen. 2013;1(2):27–31. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Сидоров Д.В., Степанов С.О., Гришин Н.А., и др. Микроволновая абляция при лечении злокачественных новообразований печени//Онкология. Журнал им. П.А. Герцена. 2013. Т. 1, № 2. С. 27–31.</mixed-citation></citation-alternatives></ref><ref id="B35"><label>35.</label><citation-alternatives><mixed-citation xml:lang="en">Lubner MG, Brace CL, Hinshaw JL, Lee FT. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol. 2010;21(8):192–203 doi: 10.1016/j.jvir.2010.04.007</mixed-citation><mixed-citation xml:lang="ru">Lubner M.G., Brace C.L., Hinshaw J.L., Lee F.T. Microwave tumor ablation: mechanism of action, clinical results, and devices//J Vasc Interv Radiol. 2010. Vol. 21, Suppl 8. P. 192–203. doi: 10.1016/j.jvir.2010.04.007</mixed-citation></citation-alternatives></ref><ref id="B36"><label>36.</label><citation-alternatives><mixed-citation xml:lang="en">Wei Y, Peng L, Li Y, et al. Clinical study on safety and efficacy of microwave ablation for primary hyperparathyroidism. Korean J Radiol. 2020;21(5):572–581. doi: 10.3348/kjr.2019.0593</mixed-citation><mixed-citation xml:lang="ru">Wei Y., Peng L., Li Y., et al. Clinical study on safety and efficacy of microwave ablation for primary hyperparathyroidism//Korean J Radiol. 2020. Vol. 21, N 5. P. 572–581. doi: 10.3348/kjr.2019.0593</mixed-citation></citation-alternatives></ref><ref id="B37"><label>37.</label><citation-alternatives><mixed-citation xml:lang="en">Schlosser K, Bartsch DK, Diener MK, et al. Total parathyroidectomy with routine thymectomy and autotransplantation versus total parathyroidectomy alone for secondary hyperparathyroidism: results of a nonconfirmatory multicenter prospective randomized controlled pilot trial. Annals of Surgery. 2016;264(5):745–753. doi: 10.1097/SLA.0000000000001875</mixed-citation><mixed-citation xml:lang="ru">Schlosser K., Bartsch D.K., Diener M.K., et al. Total parathyroidectomy with routine thymectomy and autotransplantation versus total parathyroidectomy alone for secondary hyperparathyroidism: results of a nonconfirmatory multicenter prospective randomized controlled pilot trial//Annals of Surgery. 2016. Vol. 264, N 5. P. 745–753. doi: 10.1097/SLA.0000000000001875</mixed-citation></citation-alternatives></ref><ref id="B38"><label>38.</label><citation-alternatives><mixed-citation xml:lang="en">Zhuo L, Zhang L, Peng LL, et al. Microwave ablation of hyperplastic parathyroid glands is a treatment option for end-stage renal disease patients ineligible for surgical resection. Int J Hyperthermia. 2019;36(1):29–35. doi: 10.1080/02656736.2018.1528392</mixed-citation><mixed-citation xml:lang="ru">Zhuo L., Zhang L., Peng L.L., et al. Microwave ablation of hyperplastic parathyroid glands is a treatment option for end-stage renal disease patients ineligible for surgical resection//Int J Hyperthermia. 2019. Vol. 36, N 1. Р. 29–35. doi: 10.1080/02656736.2018.1528392</mixed-citation></citation-alternatives></ref><ref id="B39"><label>39.</label><citation-alternatives><mixed-citation xml:lang="en">Copelan A, Hartman J, Chehab M, Venkatesan AM. High-Intensity focused ultrasound: current status for image-guided therapy. Semin Intervent Radiol. 2015;32(4):398–415. doi: 10.1055/s-0035-1564793</mixed-citation><mixed-citation xml:lang="ru">Copelan A., Hartman J., Chehab M., Venkatesan A.M. High-Intensity focused ultrasound: current status for image-guided therapy//Semin Intervent Radiol. 2015. Vol. 32, N 4. P. 398–415. doi: 10.1055/s-0035-1564793</mixed-citation></citation-alternatives></ref><ref id="B40"><label>40.</label><citation-alternatives><mixed-citation xml:lang="en">Suleimanov EA, Filonenko EV, Moskvicheva LI, et al. The possibility of hifu therapy at the present stage. Research and Practical Medicine Journal. 2016;3(3):76–82. (In Russ). doi: 10.17709/2409-2231-2016-3-3-8</mixed-citation><mixed-citation xml:lang="ru">Suleimanov E.A., Filonenko E.V., Moskvicheva L.I., et al. The possibility of hifu therapy at the present stage//Research and Practical Medicine Journal. 2016. Vol. 3, N 3. P. 76–82. doi: 10.17709/2409-2231-2016-3-3-8</mixed-citation></citation-alternatives></ref><ref id="B41"><label>41.</label><citation-alternatives><mixed-citation xml:lang="en">Limani K, Aoun F, Holz S, et al. Single high intensity focused ultrasound session as a whole gland primary treatment for clinically localized prostate cancer: 10-year outcomes. Prostate Cancer. 2014;2014:186782. doi: 10.1155/2014/186782</mixed-citation><mixed-citation xml:lang="ru">Limani K., Aoun F., Holz S., et al. Single high intensity focused ultrasound session as a whole gland primary treatment for clinically localized prostate cancer: 10-year outcomes//Prostate Cancer. 2014. Vol. 2014. Р. 186782. doi: 10.1155/2014/186782</mixed-citation></citation-alternatives></ref><ref id="B42"><label>42.</label><citation-alternatives><mixed-citation xml:lang="en">Chung SR, Baek JH, Suh CH, et al. Efficacy and safety of high-intensity focused ultrasound (HIFU) for treating benign thyroid nodules: a systematic review and meta-analysis. Acta Radiologica. 2020;61(12):1636–1643. doi: 10.1177/0284185120909339</mixed-citation><mixed-citation xml:lang="ru">Chung S.R., Baek J.H., Suh C.H., et al. Efficacy and safety of high-intensity focused ultrasound (HIFU) for treating benign thyroid nodules: a systematic review and meta-analysis//Acta Radiologica. 2020. Vol. 61, N 12. P. 1636–1643. doi: 10.1177/0284185120909339</mixed-citation></citation-alternatives></ref><ref id="B43"><label>43.</label><citation-alternatives><mixed-citation xml:lang="en">Ploussard G. Re: Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: multi-institutional analysis of 418 patients. Eur Urol. 2018;73(1):140–141. doi: 10.1016/j.eururo.2017.09.031</mixed-citation><mixed-citation xml:lang="ru">Ploussard G. Re: Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: multi-institutional analysis of 418 patients//Eur Urol. 2018. Vol. 73, N 1. P. 140–141. doi: 10.1016/j.eururo.2017.09.031</mixed-citation></citation-alternatives></ref><ref id="B44"><label>44.</label><citation-alternatives><mixed-citation xml:lang="en">Tsamatropoulos P, Valcavi R. HIFU and RFA Ablation for thyroid and parathyroid disease. Advanced thyroid and parathyroid ultrasound. Springer, Cham; 2017. doi: 10.1007/978-3-319-44100-9_36</mixed-citation><mixed-citation xml:lang="ru">Tsamatropoulos P., Valcavi R. HIFU and RFA ablation for thyroid and parathyroid disease. Advanced thyroid and parathyroid ultrasound. Springer, Cham; 2017. doi: 10.1007/978-3-319-44100-9_36</mixed-citation></citation-alternatives></ref><ref id="B45"><label>45.</label><citation-alternatives><mixed-citation xml:lang="en">Kovatcheva R, Vlahov J, Stoinov J, et al. US-guided high-intensity focused ultrasound as a promising non-invasive method for treatment of primary hyperparathyroidism. Eur Radiol. 2014;24(9):2052–2058. doi: 10.1007/s00330-014-3252-4</mixed-citation><mixed-citation xml:lang="ru">Kovatcheva R., Vlahov J., Stoinov J., et al. US-guided high-intensity focused ultrasound as a promising non-invasive method for treatment of primary hyperparathyroidism//Eur Radiol. 2014. Vol. 24, N 9. P. 2052–2058. doi: 10.1007/s00330-014-3252-4</mixed-citation></citation-alternatives></ref><ref id="B46"><label>46.</label><citation-alternatives><mixed-citation xml:lang="en">Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):179–184. doi: 10.1159/000339789</mixed-citation><mixed-citation xml:lang="ru">Khwaja A. KDIGO clinical practice guidelines for acute kidney injury//Nephron Clin Pract. 2012. Vol. 120, N 4. Р. 179–184. doi: 10.1159/000339789</mixed-citation></citation-alternatives></ref><ref id="B47"><label>47.</label><citation-alternatives><mixed-citation xml:lang="en">Daugirdas JT, Depner TA, Inrig J, et al. KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Am J Kidney Dis. 2015;66(5):884–930. doi: 10.1053/j.ajkd.2015.07.015.</mixed-citation><mixed-citation xml:lang="ru">Daugirdas J.T., Depner T.A., Inrig J., et al. KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update//Am J Kidney Dis. 2015. Vol. 66, N 5. Р. 884–930. doi: 10.1053/j.ajkd.2015.07.015.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
